Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: An oncogenic role for sphingosine kinase 2
Author: Neubauer, H.A.
Pham, D.H.
Zebol, J.R.
Moretti, P.A.B.
Peterson, A.L.
Leclercq, T.M.
Chan, H.
Powell, J.A.
Pitman, M.R.
Samuel, M.S.
Bonder, C.S.
Creek, D.J.
Gliddon, B.L.
Pitson, S.M.
Citation: Oncotarget, 2016; 7(40):64886-64899
Publisher: Impact Journals
Issue Date: 2016
ISSN: 1949-2553
Statement of
Heidi A. Neubauer, Duyen H. Pham, Julia R. Zebol, Paul A.B. Moretti, Amanda L. Peterson, Tamara M. Leclercq, Huasheng Chan, Jason A. Powell, Melissa R. Pitman, Michael S. Samuel, Claudine S. Bonder, Darren J. Creek, Briony L. Gliddon and Stuart M. Pitson
Abstract: While both human sphingosine kinases (SK1 and SK2) catalyze the generation of the pleiotropic signaling lipid sphingosine 1-phosphate, these enzymes appear to be functionally distinct. SK1 has well described roles in promoting cell survival, proliferation and neoplastic transformation. The roles of SK2, and its contribution to cancer, however, are much less clear. Some studies have suggested an antiproliferative/ pro-apoptotic function for SK2, while others indicate it has a prosurvival role and its inhibition can have anti-cancer effects. Our analysis of gene expression data revealed that SK2 is upregulated in many human cancers, but only to a small extent (up to 2.5-fold over normal tissue). Based on these findings, we examined the effect of different levels of cellular SK2 and showed that high-level overexpression reduced cell proliferation and survival, and increased cellular ceramide levels. In contrast, however, low-level SK2 overexpression promoted cell survival and proliferation, and induced neoplastic transformation in vivo. These findings coincided with decreased nuclear localization and increased plasma membrane localization of SK2, as well as increases in extracellular S1P formation. Hence, we have shown for the first time that SK2 can have a direct role in promoting oncogenesis, supporting the use of SK2-specific inhibitors as anti-cancer agents.
Keywords: sphingosine kinase 2; neoplastic transformation; oncogenesis; proliferation; tumorigenesis
Rights: Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License. PII: 11714
DOI: 10.18632/oncotarget.11714
Grant ID:
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_103587.pdfPublished Version3.86 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.